Discovering the right compound that can treat an infection such as HIV is only the first piece of the drug development puzzle. The next challenge is to make the manufacturing process more efficient—and thereby cheaper. Killugudi Jayaraman meets with the 'process chemistry' experts honing these reactions to bring down the cost of antiretrovirals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Reddy, A.R. et al. Chem. Biol. Interface 3, 201–204 (2013).
Bellani, P., Frigerio, M & Castoldi, P. US Patent 6407252 (2002).
Ripin, D.H.B. et al. Org. Process Res. Dev. 14, 1194–1201 (2010).
Crawford, K.W. et al. Lancet Infect. Dis. 12, 550–560 (2012).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jayaraman, K. Finding the right chemistry. Nat Med 19, 1200–1203 (2013). https://doi.org/10.1038/nm1013-1200
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1013-1200
